Click here to join our Discord: Real Peptide Talk
Visit our store: https://NRGBioLabs.com
Visit our blog: https://peptideresearch.us
Join our Newsletter list: https://peptideresearch.us/newsletter
YouTube: https://www.youtube.com/channel/UCc-LSRreCRMXhTVLVYsO-jg
Follow us on Facebook

In this episode, we explore the growing conversation around GLP-based weight loss compounds and a concern that many people overlook: lean muscle loss during rapid weight reduction.

While traditional GLP drugs can produce significant weight loss, researchers have observed that a meaningful portion of that loss may come from lean muscle tissue rather than body fat.

We break down why muscle preservation is so important for metabolic health and long-term weight management, and why researchers are now paying close attention to a newer investigational compound known as Retatrutide, often referred to as GLP-3.

Unlike earlier compounds that primarily reduce appetite, GLP-3 activates three metabolic hormone pathways, including the glucagon receptor, which is associated with increased energy expenditure and fat oxidation.

Could this multi-pathway approach help shift weight loss more toward fat rather than muscle?

We discuss the early research, the mechanisms behind GLP-3, and why it has quickly become one of the most closely watched developments in metabolic peptide research.